Artiva Biotherapeutics Inc (ARTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 24,430 | 21,932 | 22,897 | 22,810 | 22,171 |
| Operating Income | -24,430 | -21,932 | -22,897 | -22,810 | -22,171 |
| Other Income | 914 | 1,160 | 1,369 | 1,556 | 1,860 |
| Pre-tax Income | -23,516 | -20,772 | -21,528 | -21,254 | -20,311 |
| Net Income Continuous | -23,516 | -20,772 | -21,528 | -21,254 | -20,311 |
| Net Income | $-23,516 | $-20,772 | $-21,528 | $-21,254 | $-20,311 |
| EPS Basic Total Ops | -0.95 | -0.85 | -0.88 | -0.87 | -0.83 |
| EPS Basic Continuous Ops | -0.95 | -0.85 | -0.88 | -0.87 | -0.83 |
| EPS Diluted Total Ops | -0.95 | -0.85 | -0.88 | -0.87 | -0.83 |
| EPS Diluted Continuous Ops | -0.95 | -0.85 | -0.88 | -0.87 | -0.83 |
| EPS Diluted Before Non-Recurring Items | -0.95 | -0.84 | -0.88 | -0.87 | -0.83 |
| EBITDA(a) | $-23,764 | $-21,266 | $-22,235 | $-22,169 | $-21,543 |